BCAS4 antibody
Principal name
BCAS4 antibody
Alternative names for BCAS4 antibody
Breast carcinoma-amplified sequence 4
SwissProt ID
Q8TDM0 (Human)
Gene ID
55653 (BCAS4)
Ncbi ID
9606, NP_001010974.1, NP_001010974, NM_198799, NM_001010974, NP_060313, NP_942094, CAI23006, NM_017843
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of BCAS4 antibody
- Kit Component:
- - KN215772G1, BCAS4 gRNA vector 1 in pCas-Guide vector
- KN215772G2, BCAS4 gRNA vector 2 in pCas-Guide vector
- KN215772D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual




Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA306934 | BCAS4 antibody |
||||||
| Rabbit Polyclonal BCAS4 Antibody | |||||||
![]() |
Rabbit | IgG | Aff - Purified | Hu, Ms | E, ICC/IF, P, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA313274 | BCAS4 antibody |
||||||
| Rabbit polyclonal anti-BCAS4 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA351004 | BCAS4 antibody |
||||||
| Rabbit Polyclonal Anti-BCAS4 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| AP23508PU-N | BCAS4 (N-term) antibody |
||||||
![]() |
Rabbit | Hu, Ms | E, P, WB |
50 µg /
€425.00
|
|||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP315772 | BCAS4 (transcript variant 1) |
||||
| Recombinant protein of human breast carcinoma amplified sequence 4 (BCAS4), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP318580 | BCAS4 (transcript variant 2) |
||||
| Recombinant protein of human breast carcinoma amplified sequence 4 (BCAS4), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY404796 | BCAS4 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY423248 | BCAS4 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |











+2 additional images




